decisionhealth Newsletters, Answer Books - 2010 Issue 1 (January)
Answer_Book / Referral_Prohibitions / EPO_and_other_dialysis_drugs
Subscribe or sign in to view the full article.
Article Overview
This article provides a focused reference for ESRD-related outpatient prescription drugs and related billing identifiers discussed in the context of Stark referral prohibitions. It is intended for coding, compliance, and reimbursement professionals who need to know which dialysis-related drug entries are covered in this policy update and how the article organizes the list of affected identifiers.
Why This Topic Matters
It helps readers quickly determine whether the premium content is relevant to ESRD facility drug billing and referral-compliance review, while preserving the full code-specific details for the article itself.
What You Will Learn
- The scope of the ESRD facility outpatient prescription drug topic addressed by the article.
- How the article frames the policy context around referral prohibitions.
- Which code sets and identifiers are referenced in the dated reference list.
- What kinds of dialysis-related drugs are included in the article's coverage.
Who Should Read This
- Medical coders
- Compliance professionals
- Revenue cycle staff
- Billing specialists
- ESRD facility administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com